Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 2005

Clinicopathological Features of Lupus Anticoagulant: Experience at AFIP During Last Seven Years

Muhammad Ayyub, M Khan, Masood Anwar, Amin Waqar, Waqar Ali, Tassawar Hussain, Muhammad Luqman, Nadira Sultana, Karamat Karamat, Wasif Saif

Med Sci Monit 2005; 11(11): CR536-539 :: ID: 430368


Background: The lupus anticoagulant (LA) belongs to family of immunoglobulins,most commonly an IgG isotype. These antibodies have been identified most frequently in association withthromboembolic events, recurrent fetal loss and thrombocytopenia. The aim of the present study was toevaluate the presenting clinical and pathological features in patients LA positive presenting at AFIPRawalpindi over the period of Jan 1993 to Nov 2000. Material/Methods: Retrospective analysis of patientspresenting with positive LA was carried out. Results: 1583 suspected cases were screened for LA including1370 females and 213 males. 1024 cases presented with history of recurrent abortions, 292 with thrombosis,152 with thrombotic strokes before the age of 45 years, 52 with thrombocytopenia and 63 with miscellaneousdisorders. Out of 1024 patients tested for recurrent abortions, 130 (13%) females were positive for lupusanticoagulant. Ten (6.5%) of 152 patients presenting with strokes were found positive. Out of 292 casespresenting with thrombosis 17 (5.9%) were found positive. Conclusions: The lupus anticoagulant prevalencein Pakistani patients with recurrent fetal loss, stroke and thrombosis is statistically significant.Clinicians should be made aware of association of LA with various diseases. The successful managementof these patients depends upon close liaison with obstetricians, physicians and haematologists.

Keywords: Antiphospholipid Syndrome - diagnosis, Abortion, Habitual - immunology, Lupus Coagulation Inhibitor - analysis, Pregnancy, Stroke - immunology, Thromboembolism - immunology

Add Comment 0 Comments


01 February 2024 : Editorial  

Editorial: Global Health Concerns as Vaccine-Preventable Infections Including SARS-CoV-2 (JN.1), Influenza, Respiratory Syncytial Virus (RSV), and Measles Continue to Rise

Dinah V. Parums

DOI: 10.12659/MSM.943911

Med Sci Monit 2024; 30:e943911


In Press

08 Feb 2024 : Clinical Research  

Predictors of Mortality in Veterans with Amyotrophic Lateral Sclerosis: Respiratory Status and Speech Disor...

Med Sci Monit In Press; DOI: 10.12659/MSM.943288  


25 Feb 2024 : Clinical Research  

Patterns and Outcomes of Traumatic Suicides: A Retrospective Study of 132 Patients Admitted to a Turkish Me...

Med Sci Monit In Press; DOI: 10.12659/MSM.943505  


01 Feb 2024 : Review article  

Review of the Evaluation of Pulmonary Hypoplasia as an Important Determinant of Clinical Outcomes in Infant...

Med Sci Monit In Press; DOI: 10.12659/MSM.943259  


19 Feb 2024 : Clinical Research  

Diagnostic Accuracy of Ileocolic Artery and Vein Diameter for Acute Appendicitis

Med Sci Monit In Press; DOI: 10.12659/MSM.943846  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750